A multicenter, randomized, controlled, phase II trial for comparing radical concurrent chemoradiotherapy with/without Toripalimab (JS001) and consolidated immunotherapy in locally advanced esophageal squamous cell carcinoma
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Toripalimab (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 04 Aug 2020 New trial record